EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chimeric PRR T-cell-engager targeting cell surface β-1,3-glucan for invasive candidiasis

Yu Fang Sun, Shi Yu Guo, Si Qi Wang, Rui Tong Li, Xi Ran Qiu, Xing Chen Dong, Shuang Liu, Hui Shen, Mao Mao An iD

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1013508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Yu Fang Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: beta-Glucans, Candidiasis, Invasive, Lectins, C-Type, T-Lymphocytes. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive candidiasis, primarily caused by Candida albicans , represents the most common fungal disease among hospitalized patients and poses a significant threat to human health. Intrinsic or acquired immunosuppression serves as a critical risk factor predisposing individuals to this disease, while simultaneously reducing the efficacy of conventional antifungal therapies and worsening clinical outcomes. Given the central role of immune dysfunction in the pathogenesis of invasive candidiasis, immunotherapeutic strategies hold substantial promise. We targeted dectin-1, the primary pattern recognition receptor for β-1,3-glucan, by engineering XJ104, a bispecific T-cell engager that fuses dectin-1 to the light chains of an anti-CD3 monoclonal antibody. This construct is designed to bridge Candida β-1,3-glucan with CD3 on T cells, thereby inducing anti- Candida immunity. Our results demonstrate that XJ104 exhibits high specificity for β-1,3-glucan and activates effector cells in a Candida -dependent manner in vitro . In murine models, XJ104 enhances Th1 and Th17 responses and confers significant protection against both C. albicans and non-albicans infections. Crucially, CD3 + T-cell depletion and cytokine neutralization abolished this protection, confirming the T-cell-dependent protective efficacy of XJ104. These results establish that enhancing the endogenous T-cell function represents an effective strategy against invasive candidiasis. In conclusion, our study presents a novel therapeutic approach that bridges T cells and Candida pathogens, promoting robust Candida -specific immunity and controlling invasive infections caused by Candida spp . These findings underscore the potential of XJ104 as a clinically promising immunotherapy for the treatment of invasive candidiasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-GlucansCandidiasis, InvasiveLectins, C-TypeT-LymphocytesAnimalsMiceCandida albicansHumansMice, Inbred C57BLTh17 CellsFemaleCD3 ComplexTh1 CellsRecombinant Fusion ProteinsDectin-1

Substanzen

beta-GlucansLectins, C-TypeCD3 ComplexRecombinant Fusion ProteinsDectin-1beta-1,3-glucan

Autor:innen und Institutionen

  • Department of Pharmacology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Starmab Biologics (Suzhou) Co., Ltd., Shanghai, China.
  • Department of Clinical Laboratory Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

ORCID-Profile: Mao Mao An

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Sun, Y. F., Guo, S. Y., Wang, S. Q., Li, R. T., Qiu, X. R., Dong, X. C., Liu, S., Shen, H., & An, M. M. (2025). Chimeric PRR T-cell-engager targeting cell surface β-1,3-glucan for invasive candidiasis. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013508

Vancouver

Sun YF, Guo SY, Wang SQ, Li RT, Qiu XR, Dong XC, et al. Chimeric PRR T-cell-engager targeting cell surface β-1,3-glucan for invasive candidiasis. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013508

BibTeX
@article{Sun2025,
  author = {Sun, Yu Fang and Guo, Shi Yu and Wang, Si Qi and Li, Rui Tong and Qiu, Xi Ran and Dong, Xing Chen and Liu, Shuang and Shen, Hui and An, Mao Mao},
  title = {Chimeric PRR T-cell-engager targeting cell surface β-1,3-glucan for invasive candidiasis},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1013508}
}
Kostenlos starten →